Skip to main content
Clinical Trials/ISRCTN72989363
ISRCTN72989363
Completed
未知

A proof of concept investigation to evaluate the effectiveness of the plastic detection comb (PDC) comb, a Class I medical device, for removal of head louse eggs and nits

KSL Consulting (Denmark)0 sites25 target enrollmentOctober 31, 2014

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
KSL Consulting (Denmark)
Enrollment
25
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 31, 2014
End Date
July 8, 2015
Last Updated
5 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
KSL Consulting (Denmark)

Eligibility Criteria

Inclusion Criteria

  • 1\. People aged 4 years and over with no upper age limit
  • 2\. People who, upon examination, are confirmed to have head louse eggs and/or nits present in their hair
  • 3\. People who give written informed consent or, if the participant is under 16 years of age, whose parent/guardian gives written informed consent to participate in the study

Exclusion Criteria

  • 1\. People with a secondary bacterial infection of the scalp (e.g. impetigo) or who have an active long\-term scalp condition other than head lice (e.g. psoriasis of the scalp)
  • 2\. Pregnant or nursing mothers
  • 3\. People who have already participated in this clinical study

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Phase 1
The effect of lanreotide on therapy resistant gastro-esophageal refluxpatients with persistent endoscopic reflux in spite of maximal medical therapy with PPI 2 x 40 mg pantoprazole before breakfast and dinner and 300 mg of H2 blocker ranitidine at bedtime AND continuing pathological reflux proven on impedancemetry.MedDRA version: 14.1Level: LLTClassification code 10017924Term: Gastroesophageal refluxSystem Organ Class: 100000004856Therapeutic area: Diseases [C] - Digestive System Diseases [C06]
EUCTR2013-004232-29-BEZ Brussel15
Active, not recruiting
Not Applicable
A Phase 2 Proof of Concept Study to Evaluate the Efficacy, Safety and Pharmacokinetics of the HDAC Inhibitor 4SC-201 in Patients with Relapsed or Refractory Hodgkin’s Lymphoma - SAPHIRE
EUCTR2009-014699-24-CZ4SC AG45
Completed
Not Applicable
Evaluation of a bespoke e-health platform on general health and wellbeing in young Australians: a pilot study
ACTRN12616000163404niversity of Sydney300
Not yet recruiting
Phase 1
Extended intensive care in cases of brain death due to traumatic brain injury having diffuse axonal injuryHealth Condition 1: - Health Condition 2: S062- Diffuse traumatic brain injuryHealth Condition 3: S062- Diffuse traumatic brain injuryHealth Condition 4: S062- Diffuse traumatic brain injury
CTRI/2021/06/033958Himanshu Bansal Foundation
Recruiting
Not Applicable
Open pilot trial of a prototype emotional wellbeing app for adolescentsAnxietyDepression
ACTRN12618000273280niversity of Auckland40